Polyvaccine: joining the links in the cascade of type 1 diabetes
- Author:
Shivani DESAI
1
;
Ramesh R. BHONDE
;
Sameer S. PAREKH
Author Information
- Publication Type:Review article
- From:Clinical and Experimental Vaccine Research 2021;10(1):1-5
- CountryRepublic of Korea
- Language:English
- Abstract: The incidence of type 1 diabetes mellitus (T1DM), an autoimmune disorder, has ascended considerably with around 98,200 and 15,900 incidents in children below 15 years of age, globally and in India, respectively. This is typically due to environmental changes leading to genetic modifications. Also, T1DM encompasses the presence of autoantigens and many other etiologies which can be targeted by proper immunization. In this paper, we consciously discuss and collate various candidate triggers of islet autoimmunity and other factors expected to promote progression of T1DM. This paper bridges all the mechanisms caused by these factors and linking them with each other. We have also highlighted on the novel corona virus as a trigger for T1DM. Finally, we suggest that an amalgamated model of polyvaccine can batter the condition by inducing protection against various triggers of T1DM.
